Literature DB >> 10604301

Mouse genetics: a tool to help unlock the mechanisms of glaucoma.

S W John1, M G Anderson, R S Smith.   

Abstract

Gene characterization holds great promise for understanding molecular mechanisms of disease. Although glaucoma gene identification is very valuable and allows assessment of an individual's genetic risk, it is not by itself sufficient to answer detailed questions about pathogenesis. Despite the recent identification of a number of glaucoma genes, there are still many questions regarding the ways in which mutations in these genes cause disease. The mouse system, including the ability to alter specific genes, provides a powerful experimental system for hypothesis testing and molecular dissection of pathogenesis subsequent to gene identification. The ability to control both genetic and environmental factors will allow the use of mice to identify modifier genes that alter complex glaucoma phenotypes and that are especially difficult to identify in human families. By providing a bridge between gene identification and tests of gene function, mouse studies will be an important complement to those in humans and other species. This article summarizes the recent use of mice and the future potential of applying approaches of mouse genetics to intraocular pressure and glaucoma research.

Entities:  

Mesh:

Year:  1999        PMID: 10604301

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  28 in total

1.  A mouse model of elevated intraocular pressure: retina and optic nerve findings.

Authors:  Ronald L Gross; Jianzhong Ji; Peter Chang; Mark E Pennesi; Zhuo Yang; Jian Zhang; Samuel M Wu
Journal:  Trans Am Ophthalmol Soc       Date:  2003

2.  Central corneal thickness does not correlate with TonoLab-measured IOP in several mouse strains with single transgenic mutations of matricellular proteins.

Authors:  Ayan Chatterjee; Dong-Jin Oh; Min Hyung Kang; Douglas J Rhee
Journal:  Exp Eye Res       Date:  2013-06-24       Impact factor: 3.467

3.  Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes.

Authors:  Alexandra Boussommier-Calleja; Jacques Bertrand; David F Woodward; C Ross Ethier; W Daniel Stamer; Darryl R Overby
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-24       Impact factor: 4.799

Review 4.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

5.  A comparison of trabecular meshwork sphingolipids and ceramides of ocular normotensive and hypertensive states of DBA/2J mice.

Authors:  Yenifer Guerra; Ayman J Aljohani; Genea Edwards; Sanjoy K Bhattacharya
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-09       Impact factor: 2.671

6.  High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma.

Authors:  Michael G Anderson; Richard T Libby; Douglas B Gould; Richard S Smith; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-09       Impact factor: 11.205

Review 7.  The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Authors:  Jessy John Alexander; Aileen Judith Anderson; Scott Robert Barnum; Beth Stevens; Andrea Joan Tenner
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

Review 8.  Segmental outflow of aqueous humor in mouse and human.

Authors:  Teresia A Carreon; Genea Edwards; Haiyan Wang; Sanjoy K Bhattacharya
Journal:  Exp Eye Res       Date:  2016-08-03       Impact factor: 3.467

9.  Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.

Authors:  Maher Saleh; Mahesh Nagaraju; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

10.  IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice.

Authors:  Mahesh Nagaraju; Maher Saleh; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.